NovoCure’s electric field-therapy targets cancer cells’ charged components as they divide, reproduce and spread. Credit: Shutterstock/Magic mine.

Belfast-based ProAxsis has been awarded an Innovate UK grant to support a project to develop a remote respiratory monitoring tool.

Alongside social enterprise partner the Centre for Public Innovation (CPI), ProAxsis aims to enhance the sample processing required for its previously developed NEATstik point-of-care test, a tool that allows levels of active neutrophil elastase (NE) – an enzyme associated with respiratory diseases, including chronic obstructive pulmonary disease (COPD) – to be measured within ten minutes.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

The plan is to integrate NEATstik and other respiratory health measures into a remote patient monitoring tool, so patients can conduct the test at home, and healthcare professionals can observe the results alongside other health data.

As project lead, ProAxsis has been allocated £333,520 of the £491,154 grant while CPI has received £157,633.

ProAxsis chairperson Alan Markey commented: “Securing this grant highlights the pioneering work being conducted at ProAxsis.

“We are excited about collaborating with CPI to advance remote patient monitoring in respiratory disease, with the support of Innovate UK, the UK’s leading innovation agency.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Tom Harvey, chief technologist of HealthTech at CPI, said: “CPI is committed to creating a lasting impact through close collaboration with our partners.

“That’s why we are delighted to be working with ProAxsis on this new project which seeks to transition an existing diagnostic test out of the clinic and closer to the point of care.’’

According to GlobalData’s medical device pipeline, 22 remote patient monitoring devices are in various stages of development globally. Meanwhile, 41 respiratory assist devices are in development globally, of which 17 are in active development. The company’s data also shows that ProAxsis and its subsidiaries are currently working on the development of ten products that fall under the in vitro diagnostics markets.